Surrogates in trials supporting European marketing authorisations of medicines for amyloidosis, cystic fibrosis, hepatitis C and idiopathic pulmonary fibrosis
Abstract
Meeting abstract P063 from 2000 Meeting of the British-Pharmacological-Society (PHARMACOLOGY)